Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis, Minnesota.
Department of Nutritional Sciences, The Pennsylvania State University, University Park, Pennsylvania.
Physiology (Bethesda). 2022 Nov 1;37(6):311-322. doi: 10.1152/physiol.00007.2022. Epub 2022 Aug 9.
A surge in the prevalence of obesity and metabolic syndrome, which promote systemic inflammation, underlies an increase in cardiometabolic disease. Free fatty acid receptor 4 is a nutrient sensor for long-chain fatty acids, like ω3-polyunsaturated fatty acids (ω3-PUFAs), that attenuates metabolic disease and resolves inflammation. Clinical trials indicate ω3-PUFAs are cardioprotective, and this review discusses the mechanistic links between ω3-PUFAs, free fatty acid receptor 4, and attenuation of cardiometabolic disease.
肥胖症和代谢综合征患病率的上升,促进了全身炎症的发生,这是心血管代谢疾病增加的基础。游离脂肪酸受体 4 是长链脂肪酸(如 ω3-多不饱和脂肪酸(ω3-PUFA))的营养传感器,可减轻代谢疾病并缓解炎症。临床试验表明 ω3-PUFA 具有心脏保护作用,本综述讨论了 ω3-PUFA、游离脂肪酸受体 4 和减轻心血管代谢疾病之间的机制联系。